Your browser doesn't support javascript.
loading
Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer.
Spira, Alexander; Awada, Ahmad; Isambert, Nicolas; Lorente, David; Penel, Nicolas; Zhang, Yue; Ojalvo, Laureen S; Hicking, Christine; Rolfe, P Alexander; Ihling, Christian; Dussault, Isabelle; Locke, George; Borel, Christian.
Afiliação
  • Spira A; Department of Medical Oncology, Virginia Cancer Specialists, Fairfax, VA, United States.
  • Awada A; US Oncology Research, The Woodlands, TX, United States.
  • Isambert N; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Lorente D; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Penel N; Department of Medical Oncology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Zhang Y; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Ojalvo LS; Department of Medical Oncology, Université de Lille, Lille, France.
  • Hicking C; EMD Serono Research & Development Institute, Inc, an Affiliate of Merck KGaA, Billerica, MA, United States.
  • Rolfe PA; EMD Serono Research & Development Institute, Inc, an Affiliate of Merck KGaA, Billerica, MA, United States.
  • Ihling C; Merck Healthcare KGaA, Darmstadt, Germany.
  • Dussault I; EMD Serono Research & Development Institute, Inc, an Affiliate of Merck KGaA, Billerica, MA, United States.
  • Locke G; Merck Healthcare KGaA, Darmstadt, Germany.
  • Borel C; EMD Serono Research & Development Institute, Inc, an Affiliate of Merck KGaA, Billerica, MA, United States.
Front Oncol ; 12: 981940, 2022.
Article em En | MEDLINE | ID: mdl-36568239
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos